Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say
A report released Friday found that his pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to as much as $56.2 million at the end of 2025.
Ähnliche Seiten
Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say - Los Angeles Times
Donald Trump pharmaceutical investments: Donald Trump raised stakes in drug companies gaining from medicare exemptions, say Democrats - The Economic Times